What is the appropriate evaluation and management for an 81-year-old patient with forgetfulness and suspected dementia?

Evaluation and Management of an 81-Year-Old with Forgetfulness and Family History of Dementia

Begin with office-based cognitive screening using a validated brief tool, followed by comprehensive history, physical examination, laboratory workup, and brain imaging to establish diagnosis and rule out reversible causes 1.

Initial Cognitive Assessment

Start with a brief validated screening tool that can be completed in 1-3 minutes:

• Mini-Cog (most time-efficient)
• General Practitioner Assessment of Cognition (GPCOG)
• Verbal fluency test

If screening is abnormal, proceed to more comprehensive testing with:

• Montreal Cognitive Assessment (MoCA) or
• Mini-Mental State Examination (MMSE)

These should assess specific domains: learning and memory (particularly delayed free and cued recall), attention, executive function, visuospatial function, and language 1, 2.

Comprehensive History - Key Elements to Obtain

From the patient AND a care partner (critical for accurate assessment):

• Timeline and progression of memory symptoms
• Impact on activities of daily living (ADLs) and instrumental ADLs (finances, medications, driving)
• Behavioral or personality changes
• Language difficulties or social-behavioral abnormalities
• Complete medication review (especially anticholinergics)
• Cardiovascular risk factors (hypertension, diabetes, stroke history, midlife obesity)
• Family history details (age of onset in relatives, type of dementia if known)
• Depression screening using Geriatric Depression Scale 3, 2

Physical and Neurological Examination

Focus on:

• Neurologic deficits suggesting focal cerebral pathology
• Gait assessment and fall risk
• Sensory or motor dysfunction of cerebral origin
• Signs of cardiovascular disease
• Attentional impairments that might suggest delirium 1

Laboratory Workup

Essential tests to identify reversible causes:

• Complete blood count
• Comprehensive metabolic panel
• Thyroid function (TSH)
• Vitamin B12 level
• Consider: syphilis serology, HIV testing (if risk factors present)

2, 4

Brain Imaging

MRI of the brain is strongly recommended over CT to:

• Identify vascular disease, strokes, microbleeds
• Assess for structural abnormalities
• Rule out subdural hematoma, normal pressure hydrocephalus, tumors
• Evaluate patterns of atrophy

2, 4

Do NOT routinely order:

• Cerebrospinal fluid testing
• Genetic testing for apolipoprotein E4 allele

2

When to Refer to Specialist

Refer expeditiously if any of the following are present 1:

• Atypical examination findings (prominent language/behavioral abnormalities, focal neurologic signs)
• Uncertainty about diagnosis after initial evaluation
• Cognitive symptoms but normal performance on office testing (requires neuropsychological evaluation)
• Rapidly progressive symptoms (weeks to months)
• Early-onset (age <65 years) - though this patient is 81

The 2025 Alzheimer's Association guidelines emphasize that delays in diagnosis cause substantial distress and harm, particularly given the family history suggesting genetic risk 1.

Diagnostic Disclosure

Once diagnosis is established, communicate findings in a structured manner:

• Explain the diagnosis, stage, and prognosis clearly
• Involve the care partner - this is critical as the patient may have impaired insight
• Assess patient's understanding and capacity
• Provide personalized education for care planning
• Discuss safety considerations (driving, medication management, finances)
• Address advance care planning and Lasting Power of Attorney 1, 5

Common Pitfalls to Avoid

• Don't assume normal aging - forgetfulness with functional impairment warrants full evaluation
• Don't skip the care partner interview - patients often lack insight into deficits
• Don't delay imaging - structural causes must be excluded
• Don't miss delirium - requires urgent evaluation if present
• Don't forget medication review - anticholinergics commonly worsen cognition
• Don't overlook depression - can mimic or coexist with dementia

Pharmacologic Treatment Considerations

If Alzheimer's disease is diagnosed:

• Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) are strongly recommended for mild to moderate AD to improve cognition and daily function 6
• Memantine is strongly recommended for moderate to severe AD 6
• Both classes have favorable safety profiles with manageable side effects

The family history of dementia increases this patient's risk and makes thorough evaluation even more critical for early intervention and care planning 1, 7.